Journey Medical reports Emrosi sales up 84% in third quarter of 2026
The dermatology company said Emrosi revenue climbed to $9.0 million while cash fell to $22.3 million, with the vendor dispute payout weighing on quarterly costs.
SEC filing (2)
2 stories
The dermatology company said Emrosi revenue climbed to $9.0 million while cash fell to $22.3 million, with the vendor dispute payout weighing on quarterly costs.
SEC filing (2)